Comparative efficacy of PD-1 inhibitors plus lenvatinib and regorafenib after lenvatinib failure for advanced hepatocellular carcinoma: a real-world study.
Ren-Guo GuanJie MeiShaohua LiWenping LinMin DengWei WeiRong-Ping GuoPublished in: Hepatology international (2023)
Keyphrases